Laboratory Corp of America Holdings (LH) Stock Price, Quote & News

Company Profile

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 336-584-5171

Fax: 336-436-1569

Website: www.labcorp.com

Address:

531 South Spring Street, Burlington, United States

stewardhughes Oct. 25 at 9:25 PM

$BNTX $LH Fund rebalancing https://stocktwits.com/colindequincey/message/633715093

0 · Reply

Nikotime Oct. 24 at 11:58 PM

$LH here we go, testing highs and likely breaking out soon!

0 · Reply

Nikotime Oct. 24 at 4:56 AM

$LH Should tap that $300 ceiling and break through before the eoy I think...

0 · Reply

induscapital Oct. 21 at 2:18 PM

$LH $DGX If DGX is any cue then LH is going down from here till ER

0 · Reply

MoneyGroupLLC Oct. 21 at 9:24 AM

Enter: $LH NOV 21 2025 $300 CALLS Buy in Price: $5.35 - $5.62 Take Profit: $9.09 Stop Bleeding: $4.71 ROI Potential: 70% Exit Within: 2 Weeks https://moneygroup.us/alerts

0 · Reply

MoneyGroupLLC Oct. 20 at 12:06 PM

Enter: $LH NOV 21 2025 $290 CALLS Buy in Price: $7.70 - $9.00 Take Profit: $16.71 Stop Bleeding: $6.78 ROI Potential: 117% Exit Within: 2 Weeks https://moneygroup.us/alerts

0 · Reply

Estimize Oct. 20 at 12:03 PM

Wall St is expecting 4.13 EPS for $LH Q3 [Reporting 10/28 BMO] http://www.estimize.com/intro/lh?chart=historical&metric_name=eps&utm_conten

0 · Reply

JarvisFlow Oct. 17 at 1:54 PM

UBS has adjusted their stance on Labcorp Hldgs ( $LH ), setting the rating to Buy with a target price of 305 → 325.

0 · Reply

JarvisFlow Oct. 17 at 1:22 PM

Mizuho updates rating for Labcorp Hldgs ( $LH ) to Outperform, target set at 285 → 320.

0 · Reply

MoneyGroupLLC Oct. 16 at 11:14 PM

Enter: $LH NOV 21 2025 $290 CALLS Buy in Price: $6.30 - $6.70 Take Profit: $11.91 Stop Bleeding: $5.54 ROI Potential: 89% Exit Within: 3 Weeks https://moneygroup.us/alerts

0 · Reply

Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings

Oct 20, 2025, 9:00 AM EDT - 5 days ago

Praia Health, Providence, and Labcorp Collaborate to Transform Patient Engagement and Lab Order Adherence

Oct 8, 2025, 4:15 PM EDT - 17 days ago

Labcorp Declares Quarterly Dividend

Sep 30, 2025, 7:00 AM EDT - 25 days ago

Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities

Sep 25, 2025, 4:15 PM EDT - 4 weeks ago

Labcorp to Announce Third Quarter Financial Results on October 28, 2025

Sep 15, 2025, 8:30 AM EDT - 5 weeks ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

OPK

Sep 9, 2025, 10:26 AM EDT - 6 weeks ago

Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 27, 2025, 4:15 PM EDT - 2 months ago

Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 18, 2025, 7:00 AM EDT - 2 months ago

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease

Jul 30, 2025, 7:12 AM EDT - 3 months ago

Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search

Jul 29, 2025, 7:00 AM EDT - 3 months ago

Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU

Jul 25, 2025, 9:45 AM EDT - 3 months ago

These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings

Jul 24, 2025, 2:38 PM EDT - 3 months ago

Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript

Jul 24, 2025, 12:27 PM EDT - 3 months ago

Why Is Testing Giant Labcorp Stock Surging On Thursday?

Jul 24, 2025, 7:00 AM EDT - 3 months ago

Labcorp raises annual profit forecast on strong diagnostic testing demand

Jul 24, 2025, 6:50 AM EDT - 3 months ago

Labcorp Announces 2025 Second Quarter Results

Jul 22, 2025, 4:15 PM EDT - 3 months ago

Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp

CYH

Jun 30, 2025, 6:58 AM EDT - 4 months ago

Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low

Jun 26, 2025, 4:10 PM EDT - 4 months ago

Labcorp to Announce Second Quarter Financial Results on July 24, 2025

Jun 2, 2025, 7:00 AM EDT - 5 months ago

ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage

May 30, 2025, 7:00 AM EDT - 5 months ago

Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research

May 8, 2025, 4:15 PM EDT - 6 months ago

Labcorp to Webcast Its Annual Meeting of Shareholders May 15

Apr 29, 2025, 4:21 PM EDT - 6 months ago

Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 6:56 AM EDT - 6 months ago

Labcorp beats quarterly profit estimate on diagnostic test demand

Apr 29, 2025, 6:50 AM EDT - 6 months ago

Labcorp Announces 2025 First Quarter Results

Apr 23, 2025, 7:00 AM EDT - 6 months ago

Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions

Apr 11, 2025, 5:32 AM EDT - 7 months ago

Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics

Apr 2, 2025, 7:00 AM EDT - 7 months ago

Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease

Apr 1, 2025, 8:32 AM EDT - 7 months ago

Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide

Mar 31, 2025, 4:15 PM EDT - 7 months ago

Labcorp to Announce First Quarter Financial Results on April 29, 2025

Mar 11, 2025, 7:00 AM EDT - 8 months ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

OPK

Feb 24, 2025, 7:32 AM EST - 8 months ago

Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors

Feb 13, 2025, 2:12 PM EST - 9 months ago

Labcorp Holdings: Focus On Core Strengths For Future Growth, Initiate At 'Hold'

Feb 6, 2025, 3:42 PM EST - 9 months ago

Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript

Feb 6, 2025, 1:22 PM EST - 9 months ago

Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook

Feb 6, 2025, 6:55 AM EST - 9 months ago

Labcorp forecasts 2025 revenue above estimates on diagnostic test demand

Feb 6, 2025, 6:50 AM EST - 9 months ago

Labcorp Announces 2024 Fourth Quarter and Full Year Results

Jan 10, 2025, 4:15 PM EST - 10 months ago

Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 6:02 PM EST - 10 months ago

LABCORP DECLARES QUARTERLY DIVIDEND

Jan 8, 2025, 4:15 PM EST - 10 months ago

Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025

Jan 8, 2025, 8:15 AM EST - 10 months ago

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

BIO

Dec 17, 2024, 7:00 AM EST - 11 months ago

Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians

Nov 29, 2024, 12:16 PM EST - 11 months ago

Be Patient, Earn Dividends From Labcorp, The Leading Patient Clinical Lab Brand

Nov 26, 2024, 7:52 AM EST - 11 months ago

Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients

Nov 20, 2024, 4:23 AM EST - 1 year ago

Cinven secures Italian nod to sell minority stake in Synlab to Labcorp

Nov 19, 2024, 7:00 AM EST - 1 year ago

Labcorp CFO Glenn Eisenberg Announces Plans to Retire

ONC

Nov 4, 2024, 9:00 AM EST - 1 year ago

Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience

Oct 24, 2024, 2:00 PM EDT - 1 year ago

Labcorp Holdings Inc. (LH) Q3 2024 Earnings Call Transcript

Oct 24, 2024, 11:25 AM EDT - 1 year ago

Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact

Oct 24, 2024, 7:10 AM EDT - 1 year ago

Labcorp beats quarterly estimates on diagnostic test demand

stewardhughes Oct. 25 at 9:25 PM

$BNTX $LH Fund rebalancing https://stocktwits.com/colindequincey/message/633715093

0 · Reply

Nikotime Oct. 24 at 11:58 PM

$LH here we go, testing highs and likely breaking out soon!

0 · Reply

Nikotime Oct. 24 at 4:56 AM

$LH Should tap that $300 ceiling and break through before the eoy I think...

0 · Reply

induscapital Oct. 21 at 2:18 PM

$LH $DGX If DGX is any cue then LH is going down from here till ER

0 · Reply

MoneyGroupLLC Oct. 21 at 9:24 AM

Enter: $LH NOV 21 2025 $300 CALLS Buy in Price: $5.35 - $5.62 Take Profit: $9.09 Stop Bleeding: $4.71 ROI Potential: 70% Exit Within: 2 Weeks https://moneygroup.us/alerts

0 · Reply

MoneyGroupLLC Oct. 20 at 12:06 PM

Enter: $LH NOV 21 2025 $290 CALLS Buy in Price: $7.70 - $9.00 Take Profit: $16.71 Stop Bleeding: $6.78 ROI Potential: 117% Exit Within: 2 Weeks https://moneygroup.us/alerts

0 · Reply

Estimize Oct. 20 at 12:03 PM

Wall St is expecting 4.13 EPS for $LH Q3 [Reporting 10/28 BMO] http://www.estimize.com/intro/lh?chart=historical&metric_name=eps&utm_conten

0 · Reply

JarvisFlow Oct. 17 at 1:54 PM

UBS has adjusted their stance on Labcorp Hldgs ( $LH ), setting the rating to Buy with a target price of 305 → 325.

0 · Reply

JarvisFlow Oct. 17 at 1:22 PM

Mizuho updates rating for Labcorp Hldgs ( $LH ) to Outperform, target set at 285 → 320.

0 · Reply

MoneyGroupLLC Oct. 16 at 11:14 PM

Enter: $LH NOV 21 2025 $290 CALLS Buy in Price: $6.30 - $6.70 Take Profit: $11.91 Stop Bleeding: $5.54 ROI Potential: 89% Exit Within: 3 Weeks https://moneygroup.us/alerts

0 · Reply

SuperGreenToday Oct. 16 at 7:59 PM

$LH Share Price: $283.43 Contract Selected: May 15, 2026 $280 Calls Buy Zone: $19.38 – $23.94 Target Zone: $34.07 – $41.64 Potential Upside: 66% ROI Time to Expiration: 210 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

ZacksResearch Oct. 15 at 2:25 PM

$LH earnings preview: Will organic growth and acquisitions drive another beat? 🚀 Labcorp's Dx segment is forecasted to see an 8.4% revenue boost, while BLS could rise 7.5%, aided by Central Laboratories' performance and digital pathology capabilities. However, a negative Earnings ESP of -0.17% could be a hurdle. Find out if Labcorp can continue its streak here 👉 https://www.zacks.com/stock/news/2769002/labcorp-gears-up-to-report-q3-earnings-whats-in-store-for-the-stock?cid=sm-stocktwits-2-2769002-body-16152&ADID=SYND_STOCKTWITS_TWEET_2_2769002_BODY_16152

0 · Reply

ZacksResearch Oct. 15 at 12:06 PM

Earnings watch: Can $LH deliver this quarter? 🧠💰 The company is preparing to report its Q3 results, and investors are watching closely for signs of growth momentum and margin strength heading into year-end. Full preview of what could move the stock next 👉 https://www.zacks.com/stock/news/2769002/labcorp-gears-up-to-report-q3-earnings-whats-in-store-for-the-stock?cid=sm-stocktwits-2-2769002-teaser-16105&ADID=SYND_STOCKTWITS_TWEET_2_2769002_TEASER_16105

0 · Reply

MoneyGroupLLC Oct. 14 at 5:28 PM

Enter: $LH NOV 21 2025 $280 CALLS Buy in Price: $8.47 - $9.20 Take Profit: $16.77 Stop Bleeding: $7.45 ROI Potential: 98% Exit Within: 2 Weeks https://moneygroup.us/alerts

0 · Reply

TalkMarkets Oct. 12 at 7:00 PM

3 #Medical Service #Industry #Stocks Poised To Counter Workforce Issues $CRL $LH $TDOC https://talkmarkets.com/content/stocks--equities/3-medical-service-industry-stocks-poised-to-counter-workforce-issues?post=527878&userid=123969

0 · Reply

BioTechHealthX Oct. 12 at 5:07 PM

$LH With EPS set to jump 82% this year, investors see upside for Laboratory Corporation’s $19.5B diagnostics empire. https://biotechhealthx.com/biotech-news/labcorp-lh-trades-near-210-as-investors-bet-on-82-earnings-boom/

0 · Reply

MoneyGroupLLC Oct. 12 at 3:45 PM

Enter: $LH NOV 21 2025 $280 CALLS Buy in Price: $8.00 - $9.10 Take Profit: $18.16 Stop Bleeding: $7.04 ROI Potential: 127% Exit Within: 317 Minutes https://moneygroup.us/alerts

0 · Reply

MoneyGroupLLC Oct. 11 at 2:44 PM

Enter: $LH NOV 21 2025 $280 CALLS Buy in Price: $8.00 - $9.10 Take Profit: $18.16 Stop Bleeding: $7.04 ROI Potential: 127% Exit Within: 317 Minutes https://moneygroup.us/alerts

0 · Reply

SuperGreenToday Oct. 11 at 1:50 AM

$LH Share Price: $277.93 Contract Selected: May 15, 2026 $280 Calls Buy Zone: $16.66 – $20.58 Target Zone: $27.81 – $33.99 Potential Upside: 58% ROI Time to Expiration: 216 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

dontfeedthebashers Oct. 10 at 7:18 PM

$LH $WM Two stocks that will never go down

0 · Reply

MoneyGroupLLC Oct. 10 at 11:43 AM

Enter: $LH NOV 21 2025 $280 CALLS Buy in Price: $9.10 - $11.70 Take Profit: $12.56 Stop Bleeding: $8.01 ROI Potential: 38% Exit Within: 322 Minutes https://moneygroup.us/alerts

0 · Reply

SuperGreenToday Oct. 9 at 10:34 PM

$LH Share Price: $277.78 Contract Selected: May 15, 2026 $280 Calls Buy Zone: $16.66 – $20.58 Target Zone: $28.62 – $34.97 Potential Upside: 62% ROI Time to Expiration: 217 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Market Cap	23.60B
Revenue (ttm)	13.01B
Net Income (ttm)	746.00M
EPS (ttm)	N/A
PE Ratio	18.68
Forward PE	17.35
Profit Margin	5.73%
Debt to Equity Ratio	0.60

Volume	698,700
Avg Vol	499,212
Day's Range	N/A - N/A
Shares Out	83.10M
Stochastic %K	20%
Beta	0.89
Analysts	Strong Sell
Price Target	$301.76